The Georgia Cancer Center at Augusta University brings together a team of basic science researchers, clinicians, radiation oncologists, nurse navigators and patient support staff to create a community fostering innovation and care focused on improving the lives of our patients. This team approach is focused on patients across the state of Georgia and neighboring states providing access to more first-in-the-nation clinical trials, world-renowned experts and a multidisciplinary approach that keeps the patient at the center of care. Research at the Georgia Cancer Center’s M. Bert Storey Research Building focuses on the most promising pathways for the prevention and treatment of cancer. Several of our researchers are involved with investigator-initiated clinical trials, transitioning their research into the clinic.
December 21, 2021
Article
Jorge E. Cortes, MD, has been an investigative leader for nearly 30 years in the development of numerous leukemia treatments.
October 08, 2021
Article
The Paceline Ride, LLC team delivered a check for $126,000 to the Georgia Cancer Center at Augusta University.
October 01, 2021
Article
The Augusta University community is encouraged to participate in this year’s Paceline bicycle ride on October 16.
April 24, 2020
Video
Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the challenges of using ruxolitinib (Jakafi) in patients with myeloproliferative neoplasms (MPNs).
April 14, 2020
Article
Jorge E. Cortes, MD, discusses managing treatment toxicities to optimize therapeutic outcomes in patients with CML and MPNs.
March 19, 2020
Article
Jorge E. Cortes, MD, discusses the evolution of multiple myeloma treatment, the role of BCMA-directed therapies, and remaining questions that need to be addressed in this space
March 19, 2020
Video
Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the advantage of BCMA-targeted therapy in multiple myeloma.
January 13, 2018
Video
Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.
November 09, 2017
Video
Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the GOG/NRG-0265 study in cervical cancer.
July 12, 2017
Article
The future of treatment for ovarian cancer may lie in immunotherapy combinations with PARP inhibitors or checkpoint inhibitors.